You are very optimistic. Medics will sell expensive snake oil treatment to desperate families. For example, from the bottom of https://en.wikipedia.org/wiki/Breast_cancer#History
> In the 1980s and 1990s, thousands of women who had successfully completed standard treatment then demanded and received high-dose bone marrow transplants, thinking this would lead to better long-term survival. However, it proved completely ineffective, and 15–20% of women died because of the brutal treatment.
I think you misunderstood. My point was that it would benefit the families because a company would gladly pay a million bucks to give a dying cancer patient the first human dose of 40 drugs they haven’t yet done any testing on, just to get quick human feedback.
The “patient” in that scenario won’t likely get any benefit from the money, but the family they leave behind would.
Obviously this is not something we want to actually see happening, but the cynic in me know that if a company can save billions by skipping all trials and going straight to “dying human” they will, and they’d be happy to pay the expendable subject a million or even more, they still come out net positive.
Allowing dying patients to make those sorts of deals with pharmaceuticals is just as horrible in the grander scale of things, they just stand to save a lot more costs and gain a lot more profits than Netflix would in a “Running Man” scenario.
The decision should be just because a patient and a doctor, because the consequences of such decisions are more far reaching than just those two. We have a well established framework for what a drug needs to prove before they can reasonable be allowed to be given to any human being, no matter their situation, and that barrier of entry is there for a multitude of good reasons. Discarding it just because a specific patient is at risk of dying or because you can get consent is not helping patients.